These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3290710

  • 41. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 42. [Immunosuppressive treatment of multiple sclerosis].
    Frick E.
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract] [Full Text] [Related]

  • 43. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U, Haller P, Haas J, Pocklington P, Deicher H.
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
    Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, Wiertlevski S, Defer G, Gout O, Berthier F, Danzon A.
    Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
    [Abstract] [Full Text] [Related]

  • 46. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul 23; 2(8604):179-83. PubMed ID: 2899660
    [Abstract] [Full Text] [Related]

  • 47. Stem cell transplantation for autoimmune disorders. Multiple sclerosis.
    Fassas A, Nash R.
    Best Pract Res Clin Haematol; 2004 Jun 23; 17(2):247-62. PubMed ID: 15302338
    [Abstract] [Full Text] [Related]

  • 48. Treating multiple sclerosis with monoclonal antibodies: the cons.
    Champlin RE.
    Neurology; 1988 Jul 23; 38(7 Suppl 2):47-9. PubMed ID: 3260357
    [Abstract] [Full Text] [Related]

  • 49. [EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].
    Flachenecker P, Hartung HP.
    Nervenarzt; 1996 Apr 23; 67(4):277-82. PubMed ID: 8684505
    [Abstract] [Full Text] [Related]

  • 50. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 51. [Therapy of multiple sclerosis].
    Harrer G.
    Wien Med Wochenschr; 1985 Jan 31; 135(1-2):42-5. PubMed ID: 2983502
    [Abstract] [Full Text] [Related]

  • 52. Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.
    Milanese C, La Mantia L, Salmaggi A, Campi A, Bortolami C, Tajoli L, Nespolo A, Corridori F.
    Ital J Neurol Sci; 1988 Feb 31; 9(1):53-7. PubMed ID: 3281916
    [Abstract] [Full Text] [Related]

  • 53. [Therapy of multiple sclerosis].
    Livrea P.
    Acta Neurol (Napoli); 1989 Feb 31; 11(2-3):165-85. PubMed ID: 2675538
    [Abstract] [Full Text] [Related]

  • 54. Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.
    J Neurol Neurosurg Psychiatry; 1987 Oct 31; 50(10):1387. PubMed ID: 3316505
    [No Abstract] [Full Text] [Related]

  • 55. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report.
    Mertin J, Rudge P, Kremer M, Healey MJ, Knight SC, Compston A, Batchelor JR, Thompson EJ, Halliday AM, Denman M, Medawar PB.
    Lancet; 1982 Aug 14; 2(8294):351-4. PubMed ID: 6124759
    [Abstract] [Full Text] [Related]

  • 56. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.
    J Neurol Neurosurg Psychiatry; 1988 Mar 14; 51(3):412-5. PubMed ID: 3283297
    [Abstract] [Full Text] [Related]

  • 57. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis.
    Gordon PA, Carroll DJ, Etches WS, Jeffrey V, Marsh L, Morrice BL, Olmstead D, Warren KG.
    Can J Neurol Sci; 1985 Feb 14; 12(1):39-44. PubMed ID: 3884114
    [Abstract] [Full Text] [Related]

  • 58. Azathioprine for multiple sclerosis.
    Casetta I, Iuliano G, Filippini G.
    J Neurol Neurosurg Psychiatry; 2009 Feb 14; 80(2):131-2; discussion 132. PubMed ID: 19151017
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.